rts logo

Zomedica Corp (ZOM) Stock Could Soon Reward Patient Investors

Zomedica Corp (AMEX: ZOM) is -35.06% lower on its value in year-to-date trading and has touched a low of $0.12 and a high of $0.23 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ZOM stock was last observed hovering at around $0.14 in the last trading session, with the day’s loss setting it -0.01%.

Currently trading at $0.13, the stock is 0.35% and -5.92% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.45 million and changing -5.25% at the moment leaves the stock -11.43% off its SMA200. ZOM registered -22.20% loss for a year compared to 6-month loss of -7.14%. The firm has a 50-day simple moving average (SMA 50) of $0.13774 and a 200-day simple moving average (SMA200) of $0.146645.

The stock witnessed a 0.85% gain in the last 1 month and extending the period to 3 months gives it a -10.34%, and is 1.25% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.00% over the week and 3.80% over the month.

Zomedica Corp (ZOM) has around 144 employees, a market worth around $127.39M and $26.08M in sales. Profit margin for the company is -214.70%. Distance from 52-week low is 8.33% and -43.11% from its 52-week high. The company has generated returns on investments over the last 12 months (-26.63%).

with sales reaching $6.26M over the same period., but quarterly earnings will post 35.40% year-over-year. Quarterly sales are estimated to grow 14.20% in year-over-year returns.

Zomedica Corp (ZOM) Top Institutional Holders

103.0 institutions hold shares in Zomedica Corp (ZOM), with institutional investors hold 8.78% of the company’s shares. The shares outstanding are 979.95M, and float is at 962.51M with Short Float at 4.51%. Institutions hold 8.62% of the Float.

The top institutional shareholder in the company is VANGUARD GROUP INC with over 29.93 million shares valued at $382.18 million. The investor’s holdings represent 3.054% of the ZOM Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 26.21 million shares valued at $334.65 million to account for 2.6742 of the shares outstanding. The other top investors are FMR LLC which holds 25.88 million shares representing 2.6405% and valued at over $330.43 million, while DRAGONEER INVESTMENT GROUP, LLC holds 2.2573 of the shares totaling 22.12 million with a market value of $282.47 million.

Zomedica Corp (ZOM) Insider Activity

The most recent transaction is an insider purchase by HEATON LARRY C II, the company’s CEO. SEC filings show that HEATON LARRY C II bought 100,000 shares of the company’s common stock on Sep 05 ’24 at a price of $0.12 per share for a total of $12500.0. Following the purchase, the insider now owns 0.4 million shares.

Zomedica Corp disclosed in a document filed with the SEC on Aug 28 ’24 that POWERS JOHNNY D (Director) bought a total of 100,000 shares of the company’s common stock. The trade occurred on Aug 28 ’24 and was made at $0.13 per share for $12900.0. Following the transaction, the insider now directly holds 2.33 million shares of the ZOM stock.

Still, SEC filings show that on Aug 20 ’24, Blair Anthony K (COO) acquired 100,000 shares at an average price of $0.14 for $14200.0. The insider now directly holds 250,000 shares of Zomedica Corp (ZOM).

Related Posts